Serotonin re-uptake inhibitors in the treatment of premenstrual dysphoria: Current state of knowledge

References

• Budeiri D J, LiWanPo A, Dornan J C. Clinical trials of 14 treatment of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynaecol 1994; 101: 689–695
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders3rd edn. American Psychiatric Association, Washington, DC 1987; 367–369
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders4th edn. American Psychiatric Association, Washington, DC 1994; 717–718
   Google Scholar
• World Health Organization. International Classification of Diseases and Related Health Problems. WHO, Geneva 1992; Volume 10, (ICD-10)
   Google Scholar
• Rubinow D R, Schmidt P J. Models for the development and expression of symptoms in premenstrual syndrome. Psychiatr Clin North Am 1989; 12: 53–68
   PubMed Web of Science ®Google Scholar
• Johnson S R. The epidemiology and social impact of premenstrual symptoms. Clin Obstet Gynecol 1987; 30: 367–376
   PubMed Web of Science ®Google Scholar
• Haskett R F, DeLongis A, Kessler R C. Premenstrual dysphoria: A community survey. Proceedings of the American Psychiatric Association Annual Meeting, Chicago, IL, May, 9–151987
   Google Scholar
• Johnson S R, McChesney C, Bean J A. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behaviour. J Reprod Med 1988; 33: 340–346
   PubMed Web of Science ®Google Scholar
• Rivera-Tovar A D, Frank E. Late luteal phase dysphoric disorder in young women. Am J Psychiatry 1990; 147: 1634–1636
   PubMed Web of Science ®Google Scholar
• Andersch B, Wendestam C, Hahn L, Ohman R. Premenstrual complaints. I. Prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gynaecol 1986; 5: 39–49
   Google Scholar
• Merikangas K R, Foeldenyi M, Angst J. The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci 1993; 243: 23–32
   PubMed Web of Science ®Google Scholar
• Ramacharan S, Love E J, Fick G H, Goldfien A. The epidemiology of premenstrual symptoms in a population based sample of 2650 urban women. J Clin Epidemiol 1992; 45: 377–378
   PubMed Web of Science ®Google Scholar
• Freeman E W, Sondheimer S, Weinbaum P J, Rickels K. Evaluating premenstrual symptoms in medical practice. Obstet Gynecol 1985; 65: 500–505
   PubMed Web of Science ®Google Scholar
• O'Brien P MS, Abukhalil I EH, Henshaw C. Premenstrual syndrome. Curr Obstet Gynecol 1995; 5: 30–37
   Google Scholar
• National Institute of Mental Health. National Institute of Mental Health. NIMH Premenstrual Syndrome Workshop Guidelines, April 14–15. Rockville, MD 1983
   Google Scholar
• Halbreich U, Endicott J. The relationship of dysphoric premenstrual changes to depressive disorder. Acta Psychiatr Scand 1985; 71: 331–338
   PubMed Web of Science ®Google Scholar
• Harrison W M, Endicott J, Nee J, et al. Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics 1989; 30: 405–411
   PubMed Web of Science ®Google Scholar
• Fava M, Pedrazzi F, Guaraldi G P, et al. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder. J Anxiety Disord 1992; 6: 325–335
   Web of Science ®Google Scholar
• McLeod D R, Hoehn-Saric R, Foster G V, Hipsley P A. The influence of premenstrual syndrome on ratings of anxiety in women with generalized anxiety disorder. Acta Psychiatr Scand 1993; 88: 248–251
   PubMed Web of Science ®Google Scholar
• Endicott J. The menstrual cycle and mood disorders. J Affect Disord 1993; 29: 193–200
   PubMed Web of Science ®Google Scholar
• Bancroft J, Rennie D, Warner P. Vulnerability to perimenstrual mood change: The relevance of a past history of depressive disorder. Psychosom Med 1994; 56: 225–234
   PubMed Web of Science ®Google Scholar
• Kaspi S P, Otto M W, Pollack M H, et al. Premenstrual exacerbation of symptoms in women with panic disorder. J Anxiety Disord 1994; 8: 131–138
   Web of Science ®Google Scholar
• Graze K K, Nee J, Endicott J. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand 1990; 81: 201–206
   PubMed Web of Science ®Google Scholar
• Roca C A, Schmidt P J, Bloch M, Rubinow D R. Implications of endocrine studies of premenstrual syndrome. Psychiatr Ann 1996; 26: 576–580
   Web of Science ®Google Scholar
• Hammarback S, Backstrom T, Holst J, et al. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 1985; 64: 393–397
   PubMed Web of Science ®Google Scholar
• Brown C S, Ling F W, Andersen R N, et al. Efficacy of depot leuprolide in premenstrual syndrome: Effect of symptom severity and type in a controlled trial. Obstet Gynecol 1994; 84: 779–786
   PubMed Web of Science ®Google Scholar
• Casper R F, Hearn M T. The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome. Am J Obstet Gynecol 1990; 162: 105–109
   PubMed Web of Science ®Google Scholar
• Casson P, Hahn P M, Van Vugt D A, Reid R L. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol 1990; 162: 99–105
   PubMed Web of Science ®Google Scholar
• Hammarback S, Backstrom T. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstet Gynecol Scand 1988; 67: 159–166
   PubMed Web of Science ®Google Scholar
• Hussain S Y, Massil J H, Matta W H, et al. Buserelin in premenstrual syndrome. Gynecol Endocrinol 1992; 6: 57–64
   PubMed Web of Science ®Google Scholar
• Mezrow G, Shoupe D, Spicer D, et al. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome. Fertil Steril 1994; 62: 932–937
   PubMed Web of Science ®Google Scholar
• Mortola J F, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotrophin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 1991; 72: 252A–252F
   PubMed Web of Science ®Google Scholar
• Muse K N, Cetel N S, Futterman L A, Yen S C. The premenstrual syndrome. Effects of a ‘medical ovariectomy’. N Engl J Med 1984; 311: 1345–1349
   PubMed Web of Science ®Google Scholar
• Smith R N, Studd J W. Estrogens and depression in women. Treatment of the postmenopausal woman: Basic and clinical aspects, R A Lobo. Raven Press, New York 1993; 129–135
   Google Scholar
• Watson N R, Studd J W, Sawas M, et al. Treatment of severe premenstrual syndrome with estradiol patches and cyclical oral norethisterone. Lancet 1989; ii: 730–732
   Google Scholar
• Rubinow D R, Schmidt P J. The treatment of premenstrual syndrome - forward into the past. N Engl J Med 1995; 332: 1574–1575
   PubMed Web of Science ®Google Scholar
• Steiner M, Lepage P, Dunn E J. Serotonin and gender specific psychiatric disorders. Int J Psych Clin Prac 1997; 1: 3–13
   PubMedGoogle Scholar
• Rapkin A. The role of serotonin in Premenstrual syndrome. Clin Obstet Gynecol 1992; 35: 629–636
   PubMed Web of Science ®Google Scholar
• Rojansky N, Halbreich U, Zander K, et al. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol Obstet Invest 1991; 31: 146–152
   PubMed Web of Science ®Google Scholar
• Steiner M. Female-specific mood disorders. Clin Obstet Gynecol 1992; 35: 599–611
   PubMed Web of Science ®Google Scholar
• Yatham L N. Is 5-HT1A receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study. Can J Psychiatry 1993; 38: 662–664
   PubMed Web of Science ®Google Scholar
• Pearlstein T B, Frank E, Rivera-Tovar A, et al. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 1990; 20: 129–134
   PubMed Web of Science ®Google Scholar
• Wurtman J J. Depression and weight gain: the serotonin connection. J Affect Disord 1993; 29: 183–192
   PubMed Web of Science ®Google Scholar
• Meltzer H Y. Serotonergic dysfunction in depression. Br J Psychiatry 1989; 155(suppl 8)25–31
   Google Scholar
• Cohen I R, Wise P M. Effects of estradiol on the diurnal rhythm of serotonin activity in microdissected brain areas of ovariectomized rats. Endocrinology 1988; 122: 2619–2625
   PubMed Web of Science ®Google Scholar
• Ladisich W. Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes. Psychoneuroendocrinol 1977; 2: 257–266
   PubMed Web of Science ®Google Scholar
• Ashby C R, Jr, Carr L A, Cook C L, et al. Alteration of platelet serotonergic mechanisms and monoamine oxidase activity on premenstrual syndrome. Biol Psychiatry 1988; 24: 225–233
   PubMed Web of Science ®Google Scholar
• Rapkin A J, Edelmuth E, Chang L C, et al. Whole blood serotonin in premenstrual syndrome. Obstet Gynecol 1987; 70: 533–537
   PubMed Web of Science ®Google Scholar
• Steege J F, Stout A L, Knight D L, Nemeroff C B. Reduced platelet tritium-labelled imipramine binding sites in women with premenstrual syndrome. Am J Obstet Gynecol 1992; 167: 168–172
   PubMed Web of Science ®Google Scholar
• Taylor D L, Mathew R H, Ho B T, Weinman M L. Serotonin levels and platelet uptake during premenstrual tension. Neuropsychobiol 1984; 12: 16–18
   PubMed Web of Science ®Google Scholar
• Bancroft J, Cook A, Davidson D, et al. Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med 1991; 21: 305–312
   PubMed Web of Science ®Google Scholar
• Fitzgerald M, Malone K M, Li S, et al. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. Am J Psychiatry 1997; 154: 556–558
   PubMed Web of Science ®Google Scholar
• Steiner M, Fairman M, Coote M, et al. Serotonergic dysregulation in LLPDD. Proceedings of the 22nd Annual Meeting of the American Society of Psychosomatic Obstetrics and Gynecology, San Diego, CA, Feb, 24–271994, 57, abstract book
   Google Scholar
• Bancroft J, Cook A. The neuroendocrine response to d-fenfluramine in women with premenstrual depression. J Affect Disord 1995; 36: 57–64
   PubMed Web of Science ®Google Scholar
• Halbreich U, Tworek H. Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int J Psychiatry Med 1993; 23: 1–27
   PubMed Web of Science ®Google Scholar
• Leibenluft E, Fiero P L, Rubinow D R. Effects of the menstrual cycle on dependent variables in mood disorders research. Arch Gen Psychiatry 1994; 51: 761–781
   PubMed Web of Science ®Google Scholar
• Hahn P M, VanVugt D A, Reid R L. A randomized, placebo-controlled crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinol 1995; 20: 193–209
   PubMed Web of Science ®Google Scholar
• Backstrom T, Hansson-Malmstrom Y, Lindhe B A, et al. Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations. Contraception 1992; 46: 253–268
   PubMed Web of Science ®Google Scholar
• Gruber A L, Hudson J I, Pope H G. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Psychiatr Clin North Am 1996; 19: 351–370
   PubMed Web of Science ®Google Scholar
• Eriksson E, Lisjo P, Sundblad C, et al. Effect of clomipramine on premenstrual syndrome. Acta Psychiatr Scand 1990; 81: 87–88
   PubMed Web of Science ®Google Scholar
• Sundblad C, Modigh K, Andersch B, Eriksson E. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo controlled trial. Acta Psychiatr Scand 1992; 85: 39–47
   PubMed Web of Science ®Google Scholar
• Sundblad C, Hedberg M A, Eriksson E. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo controlled trial. Neuropsychopharmacol 1993; 9: 133–145
   PubMed Web of Science ®Google Scholar
• Su T P, Schmidt P J, Danaceau M A, et al. Fluoxetine in the treatment of premenstrual syndrome. Neuropsychopharmacol 1997; 16: 346–356
   PubMed Web of Science ®Google Scholar
• Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 1995; 332: 1529–1534
   PubMed Web of Science ®Google Scholar
• Menkes D B, Taghavi E, Mason P A, Howard R C. Fluoxetine's spectrum of action in premenstrual syndrome. Int Clin Psychopharmacol 1993; 8: 95–102
   PubMed Web of Science ®Google Scholar
• Wood S H, Mortola J F, Chan Y F, et al. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled crossover study. Obstet Gynecol 1992; 80: 339–344
   PubMed Web of Science ®Google Scholar
• Stone A B, Pearlstein T B, Brown W A. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1991; 52: 290–293
   PubMed Web of Science ®Google Scholar
• Pearlstein T B, Stone A B. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994; 55: 332–335
   PubMed Web of Science ®Google Scholar
• Brandenburg S, Tuynman-Qua H, Verheij R, Pepplinkhuizen L. Treatment of premenstrual syndrome with fluoxetine: an open study. Int Clin Psychopharmacol 1993; 8: 315–317
   PubMed Web of Science ®Google Scholar
• Elks M. Open trial of fluoxetine therapy for premenstrual syndrome. South Med J 1993; 86: 503–507
   PubMed Web of Science ®Google Scholar
• Rickels K, Freeman E W, Sondheimer S, Albert J. Fluoxetine in the treatment of premenstrual syndrome. Curr Ther Research 1990; 48: 161–166
   Web of Science ®Google Scholar
• Veeninga A T, Westenberg H GM, Weusten J TN. Fluvoxamine in the treatment of menstrually related mood disorders. Psychopharmacol 1990; 102: 414–416
   PubMed Web of Science ®Google Scholar
• Freeman E W, Rickels K, Sondheimer S J. Fluvoxamine for premenstrual dysphoric disorder: A pilot study. J Clin Psychiatry 1996; 57(suppl 8)56–60
   PubMedGoogle Scholar
• Yonkers K A, Gullion C, Williams A, et al. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol 1996; 16: 3–8
   PubMed Web of Science ®Google Scholar
• Eriksson E, Hedberg M A, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacol 1995; 12: 167–176
   PubMed Web of Science ®Google Scholar
• Yonkers K A, Halbreich U, Freeman E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA 1997; 278: 983–988
   PubMed Web of Science ®Google Scholar
• Freeman E W, Rickels K, Sondheimer S J, Wittmaack F M. Sertraline versus desipramine in the treatment of premenstrual disorder: an open-label trial. J Clin Psychiatry 1996; 57: 7–11
   PubMed Web of Science ®Google Scholar